Study seeks to understand how different forms of data meet the needs of researchers.
Peter Mesenbrink
Advertisement
Peter Mesenbrink, Executive Director, Biostatistics, Novartis
Articles by Peter Mesenbrink
Advertisement
Latest Updated Articles
- Establishing a Basis for Secondary Use Standards for Clinical Trials
Published: March 8th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
